These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36029073)

  • 1. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.
    Kangro K; Wolberg AS; Flick MJ
    Curr Drug Targets; 2022; 23(17):1593-1602. PubMed ID: 36029073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
    Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
    Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
    Clin Chem Lab Med; 2020 Jun; 58(7):1116-1120. PubMed ID: 32172226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Rostami M; Khoshnegah Z; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.
    Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayakawa M
    Int J Lab Hematol; 2021 Aug; 43(4):813-820. PubMed ID: 33301236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer is associated with the risk of mortality in Coronavirus Disease 2019 patients.
    Shi L; Wang Y; Wang YD; Duan GC; Yang HY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8576-8579. PubMed ID: 32894563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of coagulation dysfunction in coronavirus disease 2019].
    Zhong S; Wu F; Peng N; Xie Q; Song J; Li W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1135-1138. PubMed ID: 33081906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
    Grobbelaar LM; Venter C; Vlok M; Ngoepe M; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34328172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer levels is associated with severe COVID-19 infections: A meta-analysis.
    Du WN; Zhang Y; Yu Y; Zhang RM
    Int J Clin Pract; 2021 Aug; 75(8):e14031. PubMed ID: 33474792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.
    Ramadori G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic abnormalities in COVID-19: A guided review.
    Sathler PC
    An Acad Bras Cienc; 2020; 92(4):e20200834. PubMed ID: 32844987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
    Hunt BJ; Levi M
    Br J Haematol; 2020 Aug; 190(3):e133-e134. PubMed ID: 32484901
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization.
    Aloisio E; Serafini L; Chibireva M; Dolci A; Panteghini M
    Clin Chem Lab Med; 2020 Oct; 58(11):e255-e256. PubMed ID: 32692697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.